Fig. 1. The three Wnt signalling pathways and their main components.
(A) The canonical ß-catenin pathway is initiated by Wnt binding to
Fz/Lrp, which activates Dvl, preventing ß-catenin phosphorylation through
the Apc-Axin-Gsk3ß complex. ß-Catenin accumulates in the cytoplasm
and translocates to the nucleus, where it activates transcription in
association with Tcf. Downstream of Gsk3ß, a divergent pathway controls
Map1B phosphorylation. The proposed Wnt-Ryk-Fz complex may function through
the same pathway. (B) In the planar cell polarity (PCP) pathway, the
binding of Wnt to Fz activates Dvl, which then signals either through Daam1,
activating the small Rho GTPase, or through the small Rac GTPase, which in
turn leads to JNK activation. Both GTPases then induce changes in the
cytoskeleton. (C) In the the Wnt/calcium pathway, Wnt-Fz binding
triggers PLC activation, which then hydrolyzes PIP2, generating IP3 and DAG.
IP3 leads to the release of intracellular calcium, which activates the
calcium/calmodulin dependent protein kinase II (CamKII) and
PKC.
,ß,
, G-protein subunits; Apc, adenomatous polyposis
coli; CamKII, calcium/calmodulin-dependent protein kinase II; Daam1,
dishevelled associated activator of morphogenesis 1; DAG, diacylglycerol; Dvl,
dishevelled; Fz, Frizzled receptor; Gsk3ß, glycogen synthetase kinase 3;
IP3, inositol 1,4,5-trisphosphate receptor; JNK, jun kinase; Lrp, low-density
lipoprotein receptor-related protein; Map1B, microtubule-associated protein
1B; NF-AT, nuclear factor of activated T cells; PIP2,
phosphatidylinositol-4,5-bisphosphate; PKC, protein kinase C; PLC,
phospholipase C; Rok, Rho kinase; Ryk, receptor-like tyrosine kinase; Tcf,
T-cell factor.